Mkts

AnaptysBio, Inc.

NASDAQ: ANAB
$47.73+0.82 (+1.75%)
As of Nov 3, 4:00 PM ET

Key statistics

Day range
47.3648.35
52-week range
20.1872.36
Today
Open47.36
Previous close47.73
Volume468.1K
Valuation
Market cap1.42B
P/E ratio7.27×
EPS (TTM)3.34
Income & risk
Dividend / yield—
Beta0.63
Avg volume578.0K
Discussion

ANAB News

Stories mentioning ANAB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue25,556108,24976,32022,26327,77143,11330,01710,971
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development31,40737,82441,18042,21241,997
Sales General & Admin
Total Operating Expenses60,19341,34841,61648,43355,31052,78352,77451,292
Operating Income (Loss)(34,637)66,90134,704(26,170)(27,539)(9,670)(22,757)(40,321)
Interest Income
Interest Expense
Other Expense(1.00)(3.00)0.003,5311,90221.00(5.00)0.00
Pretax Income(52,844)49,69515,113(38,591)(39,285)(21,790)(32,851)(46,651)
Tax Provision40.0081.000.0039.0044.00(6.00)0.009.00
Net Income (Loss)(52,884)49,61415,113(38,630)(39,329)(21,784)(32,851)(46,660)
Earnings Per Share (Basic)(1.84)1.730.54(1.34)(1.28)(0.77)(1.14)(1.71)
Earnings Per Share (Diluted)(1.84)1.730.52(1.34)(1.28)(0.77)(1.14)(1.71)
Weighted Average Shares Outstanding (Basic)28,69128,75827,83328,81030,64428,38228,89327,356
Weighted Average Shares Outstanding (Diluted)28,69128,75829,01828,81030,64428,38228,89327,356

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ANAB

AnaptysBio, Inc. (NASDAQ: ANAB) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANAB. It last traded at $47.73 (Nov 3, 2026, 4:00 PM ET), up 1.8% on the day. That gives AnaptysBio a market capitalisation of $1.4B and a price-to-earnings ratio of 7.3.

Over the past 52 weeks ANAB has traded between $20.18 and $72.36.

Revenue for the quarter ended Mar 31, 2026 was $25.6M; a net loss of $52.9M. Revenue was down 8.0% from $27.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$25.6M-$52.9M-206.9%
Dec 31, 2025$108.2M$49.6M45.8%
Sep 30, 2025$76.3M$15.1M19.8%
Jun 30, 2025$22.3M-$38.6M-173.5%

From AnaptysBio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…